Sophie Richard-Mouillet

Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 43 publications

From clusters to clinic: An 8-gene signature combined with mucinous component stratifies benefit of anti-CTLA-4 addition to anti-PD-1 in dMMR/MSI-H metastatic colorectal cancer.

From clusters to clinic: An 8-gene signature combined with mucinous component stratifies benefit of anti-CTLA-4 addition to anti-PD-1 in dMMR/MSI-H metastatic colorectal cancer.

Journal: European journal of cancer (Oxford, England : 1990)

Published: January 08, 2026

Acyl-CoA-binding protein as a driver of pathological aging.

Acyl-CoA-binding protein as a driver of pathological aging.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: July 07, 2025

Negative hyperselection of patients with stage III colon cancer receiving anti-EGFR-based adjuvant treatment.

Negative hyperselection of patients with stage III colon cancer receiving anti-EGFR-based adjuvant treatment.

Journal: ESMO open

Published: June 10, 2025

Prognostic Models From Transcriptomic Signatures of the Tumor Microenvironment and Cell Cycle in Stage III Colon Cancer From PETACC-8 and IDEA-France Trials.

Prognostic Models From Transcriptomic Signatures of the Tumor Microenvironment and Cell Cycle in Stage III Colon Cancer From PETACC-8 and IDEA-France Trials.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: January 31, 2025

Triggering tumorigenic signaling: Succinate dehydrogenase inhibitor (SDHi) fungicides induce oncometabolite accumulation and metabolic shift in human colon cells.

Triggering tumorigenic signaling: Succinate dehydrogenase inhibitor (SDHi) fungicides induce oncometabolite accumulation and metabolic shift in human colon cells.

Journal: Environment international

Published: December 13, 2024

ERBB2 Comprehensive Profiling and Prognostication in Stage III Colon Cancer: Findings From PETACC8 and IDEA-France Cohorts.

ERBB2 Comprehensive Profiling and Prognostication in Stage III Colon Cancer: Findings From PETACC8 and IDEA-France Cohorts.

Journal: Gastroenterology

Published: July 12, 2024

PrPC controls epithelial-to-mesenchymal transition in EGFR-mutated NSCLC: implications for TKI resistance and patient follow-up.

PrPC controls epithelial-to-mesenchymal transition in EGFR-mutated NSCLC: implications for TKI resistance and patient follow-up.

Journal: Oncogene

Published: May 23, 2024

Wnt, glucocorticoid and cellular prion protein cooperate to drive a mesenchymal phenotype with poor prognosis in colon cancer.

Wnt, glucocorticoid and cellular prion protein cooperate to drive a mesenchymal phenotype with poor prognosis in colon cancer.

Journal: Journal of translational medicine

Published: February 12, 2024

Clinical Challenges of Consensus Molecular Subtype CMS4 Colon Cancer in the Era of Precision Medicine.

Clinical Challenges of Consensus Molecular Subtype CMS4 Colon Cancer in the Era of Precision Medicine.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: December 18, 2023

DLK1/DIO3 locus upregulation by a β-catenin-dependent enhancer drives cell proliferation and liver tumorigenesis.

DLK1/DIO3 locus upregulation by a β-catenin-dependent enhancer drives cell proliferation and liver tumorigenesis.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: December 01, 2023

New hormone receptor-positive breast cancer mouse cell line mimicking the immune microenvironment of anti-PD-1 resistant mammary carcinoma.

New hormone receptor-positive breast cancer mouse cell line mimicking the immune microenvironment of anti-PD-1 resistant mammary carcinoma.

Journal: Journal for immunotherapy of cancer

Published: May 31, 2023

Downregulation of mitochondrial complex I induces ROS production in colorectal cancer subtypes that differently controls migration.

Downregulation of mitochondrial complex I induces ROS production in colorectal cancer subtypes that differently controls migration.

Journal: Journal of translational medicine

Published: May 28, 2023

Showing 1-12 of 43

Last Updated: 09/26/2026